Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Pandemic Influenza A (H1N1) Vaccine in Chronic and or Immunocompromised Patients, Elderly and Pregnants

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Volunteers able to understand and agree to participate in the study.~Exclusion Criteria:~* Have egg allergy~* Have past history of allergy to seasonal influenza vaccine~* Have received another inactivated vaccine within the prior 2 weeks or live vaccine in the past four weeks to his/her participation in the study~* Acute infectious disease during seven days prior vaccination~* Confirmed prior infection by pandemic influenza A (H1N1)~* Have participated in another clinical trial in the last 6 months~* Any other condition identified by the principal investigators which is considered not safe for enrollment of the volunteer.

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 90 Years
- Healthy Volunteers: t

Study Arms:
- Health adults (Type: None): None
- Health children (Type: None): None
- Pregnants (Type: None): None
- Elderly over 65 years old (Type: None): None
- HIV patients (Type: None): None
- Kidney transplant (Type: None): None
- Oncologic patients (Type: None): None
- Rheumatologic adult patients (Type: None): None
- Rheumatologic children patients (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).